|
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Clinical research trials and Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer. Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer clinical trial. Participants frequently obtain the most expert healthcare available for their Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer  Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
For Condition: Leukemia,Lymphoma,Head and Neck Cancer,Lung Cancer,Eye Cancer,Gastrointestinal Cancer,Oral Cancer,Reproductive Cancer
Status: No longer recruiting
Sponsor(s): National Cancer Institute (NCI) , Eastern Cooperative Oncology Group
Synopsis: RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for early-stage cancer.
Details: OBJECTIVES: I. Compare the efficacy of brief physician-initiated smoking cessation strategies vs usual care in patients with early stage cancer who are undergoing treatment in clinical oncology settings. II. Compare the sociodemographic, smoking history, and health status correlates of smoking cessation in patients treated with these regimens. III. Determine the feasibility of conducting a cancer prevention and control study in a cooperative group setting by monitoring adherence to the smoking-cessation strategies. PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are stratified according to center. Patients are randomized to 1 of 2 treatment arms. Arm I: Patients receive usual care (no special intervention). Arm II: Patients receive smoking-cessation therapy based on the 4-step intervention plan in the "Manual for Physicians" published by the National Cancer Institute. The smoking cessation coordinator and physician provide self-quitting advice and support to the patient via counseling, self-help materials, and referral to a smoking cessation counselor at the Cancer Information Service (CIS). Patients receive nicotine replacement, if indicated. Patients who express an interest in more intensive treatment are referred to local American Cancer Society or American Lung Association clinics and/or advised to call the CIS for additional local program referrals. All patients are followed at 6 and 12 months. Patients who report that they are still smoking and interested in help to quit smoking at the 12-month follow-up interview are encouraged to return to their physicians and contact the CIS for additional help quitting or for a referral to more intensive or specialized treatments in their area. PROJECTED ACCRUAL: A total of 494 patients will be accrued for this study.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training
Minimum Age/Maximum Age: 19 Years/
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Diagnosis of stage I or II bladder, colorectal, head and neck, lung, or other cancer OR Diagnosis of stage I-III testicular cancer OR Diagnosis of stage I-IV breast cancer, prostate cancer, or lymphoma Must have smoked 1 or more cigarettes within the past month or define self as a smoker Hormone receptor status: Not specified --Prior/Concurrent Therapy-- Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: Not specified Other: No prior participation in the pilot phase study --Patient Characteristics-- Age: 19 and over Sex: Not specified Menopausal status: Not specified Performance status: ECOG 0-1 Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Cardiovascular: No history of recent heart attack Other: - Not pregnant - No other imminent medical needs requiring referral to a more intensive smoking cessation regimen
Total Enrollment:
Location and Contact Information:
Overall Study Official:
PaulEngstrom, Study Chair, Eastern Cooperative Oncology Group
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
United States
Additional Information:
Study ID Numbers: CDR0000078281; E-1Y92,NCI-P93-0042
Study Start Date: June 1992
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002520
Other Leukemia Studies:
1. Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
2. Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
3. High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Related Studies:
Other Leukemia Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
|
|
|
|
|
|
|
|
